Pfizer Inc
Stocks making the biggest moves after hours: Domino’s Pizza, Ulta, Applied Materials, Palantir and more
Check out the companies making headlines in after-hours trading: Domino’s Pizza , Ulta Beauty — Shares surged about 8% after Berkshire Hathaway announced a new stake in the pizza chain in a regulatory filing. The Warren Buffett-led firm bought more than 1.2 million shares, making the stake worth around $550 million at the end of […]
Read More
Vaccine maker stocks fall as Trump chooses RFK Jr. to lead HHS
Independent presidential candidate Robert F. Kennedy Jr. makes an announcement on the future of his campaign in Phoenix, Arizona, U.S. August 23, 2024. Thomas Machowicz | Reuters Shares of vaccine makers fell on Thursday as President-elect Donald Trump nominated Robert F. Kennedy Jr., a prominent vaccine skeptic, to lead the Department of Health and Human […]
Read More
Trump says he will give RFK Jr. a major health role if he wins the White House. Here’s what that means for patients, drugmakers
Robert F. Kennedy Jr. and Republican presidential nominee and former U.S. President Donald Trump attend a campaign event sponsored by conservative group Turning Point USA, in Duluth, Georgia, U.S., October 23, 2024. Carlos Barria | Reuters Donald Trump has made one clear promise about who could help take up the government’s health reins if he […]
Read More
Bristol Myers Squibb tops earnings estimates and hikes outlook, helped by Eliquis and new drugs
The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, US, on Wednesday, Dec. 27, 2023. Adam Glanzman | Bloomberg | Getty Images Bristol Myers Squibb on Thursday reported third-quarter earnings and revenue that blew past Wall Street’s expectations thanks to its blockbuster blood thinner Eliquis and a portfolio of drugs […]
Read More
Stocks making the biggest moves midday: VF Corporation, Pfizer, F5, JetBlue and more
Check out the companies making headlines in midday trading: VF Corporation — Shares jumped more than 22%. The North Face and JanSport parent’s quarterly results beat Wall Street’s expectations for the fiscal second quarter. VF Corporation posted adjusted earnings of 60 cents per share on revenue of $2.76 billion. That is above the 37 cents […]
Read More
Stocks making the biggest moves premarket: VF Corp, McDonald’s, Pfizer, PayPal and more
Check out the companies making headlines before the bell. VF Corp – Shares soared nearly 20% following the North Face and JanSport parent’s better-than-expected quarterly results. For the fiscal second quarter, the company posted adjusted earnings of 60 cents per share on $2.76 billion in revenue. Analysts surveyed by LSEG were looking for 37 cents […]
Read More
Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales
Kena Betancur | Corbis News | Getty Images Pfizer on Tuesday reported third-quarter revenue and adjusted profit that blew past expectations as the company’s Covid vaccine and antiviral pill Paxlovid helped boost sales. The pharmaceutical giant also hiked its full-year outlook and now expects to book adjusted earnings per share of $2.75 to $2.95, up […]
Read More
Stock futures are little changed as Wall Street awaits labor data and more earnings: Live updates
Traders work on the floor of the New York Stock Exchange during morning trading in New York City. Michael M. Santiago | Getty Images Stock futures are muted Monday night as investors readied for employment data and closely followed corporate earnings releases. Dow Jones Industrial Average futures added just 13 points, sitting slightly above flat. […]
Read More
Wall Street braces for a big week ahead of the election, with megacap tech earnings, key data on tap
Wall Street is about to get hit with the newsiest week yet ahead of the election — just as the stock market has started to falter. Investors will contend with earnings results from five of the Magnificent Seven companies next week. Alphabet’s results are set to be released Tuesday. Microsoft and Meta Platforms post their […]
Read More
Merck says experimental RSV treatment protected infants in trial, paving way for potential approval
The logo for Merck is displayed on a screen at the New York Stock Exchange on Nov. 17, 2021. Andrew Kelly | Reuters Merck on Thursday said its experimental treatment designed to protect infants from respiratory syncytial virus showed positive results in a mid- to late-stage trial, bringing the company one step closer to filing […]
Read More